Atlas Trials

Study Investigating the Safety and Tolerability of Multiple Doses of PF-02545920 in Subjects With Schizophrenia

Clinical trial NCT00463372 · COMPLETED

Trial details

NCT number
NCT00463372
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
SchizophreniaSchizo-affective Disorder
Start date
2006-10-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.